awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34660607-48250CC7-88E4-4781-85C4-298A3E06475E
Q34660607-48250CC7-88E4-4781-85C4-298A3E06475E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34660607-48250CC7-88E4-4781-85C4-298A3E06475E
Emerging therapeutic targets for synovial sarcoma.
P2860
Q34660607-48250CC7-88E4-4781-85C4-298A3E06475E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34660607-48250CC7-88E4-4781-85C4-298A3E06475E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a0231762c88a8b213316feb0f7dcb01addcba009
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.